Clinical Roundup Uninterrupted Medicaid coverage improves survival for kids with cancer October 11, 2024Vol.50 No.38
Clinical Roundup Study shows an early blood test can predict survival in metastatic prostate cancer patients October 11, 2024Vol.50 No.38
Clinical Roundup Study finds common breast cancer treatments may speed aging process October 11, 2024Vol.50 No.38
Drugs & Targets FDA approves inavolisib + palbociclib + fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer October 11, 2024Vol.50 No.38
Drugs & Targets FDA clears the way for multi-center investigator-initiated study of Alpha DaRT in immunocompromised patients with recurrent cSCC October 11, 2024Vol.50 No.38
Drugs & Targets FDA grants clearance for radiation oncology tool to calculate absorbed dose of radionuclides October 11, 2024Vol.50 No.38
Drugs & Targets First in-office digital hub enhances provider efficiency and communication October 11, 2024Vol.50 No.38
Drugs & Targets Genetics and sequencing company join to explore the UG 100TM sequencing platform to advance clinical test offerings in oncology and reproductive genomics October 11, 2024Vol.50 No.38
Regulatory News ODAC votes decisively in support of PD-L1 expression as predictive biomarker for checkpoint inhibitorsVote may lead to rollback of some indications held by BMS and Merck October 04, 2024Vol.50 No.37By Jacquelyn Cobb
